Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background & Aims Alcoholic steatohepatitis (ASH) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. We studied mouse models and human tissues to identify molecules associated with ASH progression, and focused on mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets. Methods C57BL/6N mice or mice with hepatocyte-specific disruption of Fsp27 (Fsp27Hep−/− mice) were fed the Lieber-Decarli ethanol liquid diet (5% ethanol) for 10 days to 12 weeks, followed by 1 or multiple binges of ethanol (5 or 6 g/kg) during the chronic feeding. Some mice were given an inhibitor of the peroxisome proliferator-activated receptor-γ (PPARG) (GW9662). Adenoviral vectors were used to express transgenes or small hairpin (sh) RNAs in cultured hepatocytes and in mice. Liver tissue samples were collected from ethanol-fed mice or from 31 patients with alcoholic hepatitis (AH) with biopsy-proved ASH and analyzed by histologic, immunohistochemical, transcriptome, immunoblot, and real-time PCR analyses. Results Chronic-plus-binge ethanol feeding of mice, which mimics the drinking pattern of patients with AH, produced severe ASH and mild fibrosis. Microarray analyses revealed similar alterations in expression of many hepatic genes in ethanol-fed mice and humans with ASH, including upregulation of mouse Fsp27 (also called Cidec) and human CIDEC. Fsp27Hep−/− mice and mice given injections of adenovirus-Fsp27shRNA had markedly reduced ASH following chronic-plus-binge ethanol feeding. Inhibition of PPARG and cyclic AMP-responsive element binding protein H (CREBH) prevented the increases in Fsp27α and FSP27β mRNAs, respectively, and reduced liver injury in this chronic-plus-binge ethanol feeding model. Overexpression of FSP27 and ethanol exposure had synergistic effects in inducing production of mitochondrial reactive oxygen species and damage to hepatocytes in mice. Hepatic CIDEC mRNA expression was increased in patients with AH and correlated with the degree of hepatic steatosis and disease severity including mortality. Conclusion In mice, chronic-plus-binge ethanol feeding induces ASH that mimics some histological and molecular features observed in patients with AH. Hepatic expression of FSP27/CIDEC is highly upregulated in mice following chronic-plus-binge ethanol feeding and in patients with AH; this upregulation contributes to alcohol-induced liver damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · cited 1×
“(1) Chronic feeding for 8 weeks (E8w): The mice were initially fed a controlled Lieber-DeCarli diet ad libitum for 5 days (F1259SP, BioServ, Flemington, NJ) to acclimatize them to a liquid diet.”
MethodSelf-citationAlcohol and mitochondria: a dysfunctional relationship
Hoek, J. B., Cahill, A., & Pastorino, J. G. (2002) · Gastroenterology · doi:10.1053/gast.2002.33613 · Cited by 553 · cited 2×
“99) C (>9) 8 (26) 21 (68) 2 (6) Clinical Complications during hospitalization AKI(2) 8 (26) Infection (%) 9 (31)”
Mukhopadhyay, P., Rajesh, M., Haskó, G., Hawkins, B. J., Madesh, M., & Pacher, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.327 · Cited by 373
Self-citationAlcoholic liver disease: pathogenesis and new targets for therapy
Altamirano, J., & Bataller, R. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.134 · Cited by 284
Self-citationMitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis
Chacko, B. K., Srivastava, A., Johnson, M. S., Benavides, G. A., Chang, M. J., Ye, Y., Jhala, N., Murphy, M. P., Kalyanaraman, B., & Darley-Usmar, V. M. (2011) · Hepatology · doi:10.1002/hep.24377 · Cited by 122 · cited 1×
“2) Platelet count x109/L 121 (71-175) Serum Glucose (mg/dL) 103 (83-127) Serum Cholesterol (mg/dL) 121 (96-166) AST ( U/L) 128 (68-175) ALT (U/L) 44 (26-59) Serum GGT (UI/L) 378 (166-687) Serum albumin (g/dL) 2.”
Research works printed but not linked: 41
- Tsukamoto, 2001, Current concepts in the pathogenesis of alcoholic liver injury, FASEB J, 15, 1335, 10.1096/fj.00-0650rev · DOI · Paper page
- Williams, 2014, New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases, World J Gastroenterol, 20, 12908, 10.3748/wjg.v20.i36.12908 · DOI
- Lucey, 2009, Alcoholic hepatitis, N Engl J Med, 360, 2758, 10.1056/NEJMra0805786 · DOI · Paper page
- Singal, 2014, Alcoholic hepatitis: current challenges and future directions, Clin Gastroenterol Hepatol, 12, 555, 10.1016/j.cgh.2013.06.013 · DOI · Paper page
- Mathurin, 2012, Management of alcoholic hepatitis, J Hepatol, 56, S39, 10.1016/S0168-8278(12)60005-1 · DOI
- Chayanupatkul, 2014, Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment, World J Gastroenterol, 20, 6279, 10.3748/wjg.v20.i20.6279 · DOI
- Thursz, 2015, Prednisolone or pentoxifylline for alcoholic hepatitis, N Engl J Med, 372, 1619, 10.1056/NEJMoa1412278 · DOI · Paper page
- Brandon-Warner, 2012, Rodent models of alcoholic liver disease: of mice and men, Alcohol, 46, 715, 10.1016/j.alcohol.2012.08.004 · DOI · Paper page
- Ueno, 2012, Mouse intragastric infusion (iG) model, Nat Protoc, 7, 771, 10.1038/nprot.2012.014 · DOI · Paper page
- Lazaro, 2015, Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice, Hepatology, 61, 129, 10.1002/hep.27383 · DOI · Paper page
- Bertola, 2013, Mouse model of chronic and binge ethanol feeding (the NIAAA model), Nat Protoc, 8, 627, 10.1038/nprot.2013.032 · DOI · Paper page
- Xu, 2012, CIDE proteins and lipid metabolism, Arterioscler Thromb Vasc Biol, 32, 1094, 10.1161/ATVBAHA.111.241489 · DOI · Paper page
- Matsusue, 2008, Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27, Cell Metab, 7, 302, 10.1016/j.cmet.2008.03.003 · DOI · Paper page
- Yonezawa, 2011, Which CIDE are you on? Apoptosis and energy metabolism, Mol Biosyst, 7, 91, 10.1039/C0MB00099J · DOI
- Gong, 2009, CIDE proteins and metabolic disorders, Curr Opin Lipidol, 20, 121, 10.1097/MOL.0b013e328328d0bb · DOI · Paper page
- Puri, 2007, Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage, J Biol Chem, 282, 34213, 10.1074/jbc.M707404200 · DOI · Paper page
- Nishino, 2008, FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets, J Clin Invest, 118, 2808
- Hall, 2010, Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss, Obesity (Silver Spring), 18, 417, 10.1038/oby.2009.236 · doi:10.1038/oby.2009.236
- Aibara, 2013, Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver, Biol Pharm Bull, 36, 1766, 10.1248/bpb.b13-00351 · DOI
- Zatloukal, 2007, From Mallory to Mallory-Denk bodies: what, how and why?, Exp Cell Res, 313, 2033, 10.1016/j.yexcr.2007.04.024 · DOI · Paper page
- Xu, 2015, Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis, Hepatology, 61, 857, 10.1002/hep.27371 · DOI
- Langhi, 2015, CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis, Hepatology, 61, 1227, 10.1002/hep.27607 · DOI
- Zhang, 2006, Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response, Cell, 124, 587, 10.1016/j.cell.2005.11.040 · DOI · Paper page
- Claros, 1996, Computational method to predict mitochondrially imported proteins and their targeting sequences, Eur J Biochem, 241, 779, 10.1111/j.1432-1033.1996.00779.x · DOI · Paper page
- Dominguez, 2008, A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, 103, 2747, 10.1111/j.1572-0241.2008.02104.x · DOI · Paper page
- Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149 · DOI · Paper page
- Lee, 2012, Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation, Am J Transl Res, 4, 102
- Moran-Salvador, 2011, Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts, FASEB J, 25, 2538, 10.1096/fj.10-173716 · DOI · Paper page
- Matsusue, 2003, Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes, J Clin Invest, 111, 737, 10.1172/JCI200317223 · DOI · Paper page
- Ratziu, 2010, Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial, Hepatology, 51, 445, 10.1002/hep.23270 · DOI · Paper page
- Yu, 2012, Inhibition of hepatic stellate cell activation and liver fibrosis by fat-specific protein 27, Mol Cell Biochem, 369, 35, 10.1007/s11010-012-1366-z · DOI
- Tanaka, 2015, Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice, J Biol Chem, 290, 3092, 10.1074/jbc.M114.605980 · DOI · Paper page
- Bertola, 2013, Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin, Hepatology, 58, 1814, 10.1002/hep.26419 · DOI · Paper page
- Dominguez, 2008, A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, 103, 2747, 10.1111/j.1572-0241.2008.02104.x · DOI · Paper page
- Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149 · DOI · Paper page
- Affo, 2013, Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis, Gut, 62, 452, 10.1136/gutjnl-2011-301146 · DOI · Paper page
- Ki, 2010, Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3, Hepatology, 52, 1291, 10.1002/hep.23837 · DOI · Paper page
- Matsusue, 2008, Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27, Cell Metab, 7, 302, 10.1016/j.cmet.2008.03.003 · DOI · Paper page
- Zhang, 2006, Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response, Cell, 124, 587, 10.1016/j.cell.2005.11.040 · DOI · Paper page
- Sun, 2006, STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice, Hepatology, 44, 955, 10.1002/hep.21344 · DOI · Paper page
- Iimuro, 1997, Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males, Am J Physiol, 272, G1186
Cited by
Alcohol-associated liver disease
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176345 · Cited by 359
Self-citationAlcohol effects on hepatic lipid metabolism
Jeon, S., & Carr, R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.r119000547 · Cited by 326
“steatosis in human alcoholic hepatitis patients (104).”
Pyroptosis by caspase11/4‐gasdermin‐D pathway in alcoholic hepatitis in mice and patients
Khanova, E., Wu, R., Wang, W., Yan, R., Chen, Y., French, S. W., Llorente, C., Pan, S. Q., Yang, Q., Li, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29645 · Cited by 228
“These results were compared to liver microarray data on AH patient versus control subjects as reported.((10)) Because the patient data do not have a group representing cASH, we first compared differentially regulated genes in AH patients versus control subjects with differentially regulated genes and proteins in AH mi…”
BackgroundResultSelf-citationLefebvre, P., Lalloyer, F., Baugé, E., Pawlak, M., Gheeraert, C., Dehondt, H., Vanhoutte, J., Woitrain, E., Hennuyer, N., Mazuy, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92264 · Cited by 117
“Accordingly, induction of the expression of the profibrotic Ctgf (50) was significantly lower in Dpt–/– mice (Figure 5B), as well as the expression of desmin (Des), a marker of HSC activation (51), and of Cidec, which may contribute to liver damage (52).”
BackgroundAlcoholic hepatitis: Translational approaches to develop targeted therapies
Mandrekar, P., Bataller, R., Tsukamoto, H., & Gao, B. (2016) · Hepatology · doi:10.1002/hep.28530 · Cited by 115
“However, hepatocellular damage and inflammation caused by chronic-plus-binge ethanol feeding are moderate and transient.((23,49)) Further, many AH patients are on a Western diet and binge drink weekly on top of heavy daily alcohol intake, and it is important to study how alcohol drinking and obesity synergistically in…”
BackgroundMethodResultInfluentialSelf-citation
Metadata
- Authors
- Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., Matsubara, T., Mukhopadhyay, P., Kimura, S., Pacher, P., Gonzalez, F. J., Bataller, R., & Gao, B.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 149
- Issue
- 4
- Pages
- 1030-1041.e6
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2100993843
- Cited by
- 145
- References
- 5
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institutes of Health (1U01AA021908-01, 2012CB518002, 81470557)
- National Key Research and Development Program of China (1U01AA021908-01, 2012CB518002, 81470557)
- National Institute on Alcohol Abuse and Alcoholism (1U01AA021908-01, 2012CB518002, 81470557)
- National Natural Science Foundation of China (1U01AA021908-01, 2012CB518002, 81470557)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. https://app.cochat.ai/papers/10.1053/j.gastro.2015.06.009
- The paper
- Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., Matsubara, T., Mukhopadhyay, P., Kimura, S., Pacher, P., Gonzalez, F. J., Bataller, R., & Gao, B. (2015). Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology. https://doi.org/10.1053/j.gastro.2015.06.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.